Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study (4520)
James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Perić, Hiroyuki Murai, Antonio Guglietta, Peter Ulrichts, Tony Vangeneugden, Kimiaki Utsugisawa, Jan J.G.M. Verschuuren, Renato Mantegazza
Abstract
To evaluate the safety and efficacy of efgartigimod in patients with generalized MG.
Topics & Concepts
TolerabilityMyasthenia gravisMedicinePhase (matter)Internal medicinePediatricsAdverse effectPhysicsQuantum mechanicsMyasthenia Gravis and ThymomaParkinson's Disease and Spinal Disorders